| Ms Debra K Martin, NP | |
|
1180 Saint Christopher Dr, Ashland, KY 41101-7055 | |
| (606) 833-6243 | |
| (606) 833-4094 |
| Full Name | Ms Debra K Martin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1180 Saint Christopher Dr, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760733349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3007652 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Eating a balanced diet and preparing your food in the correct way may be your best defense against developing cancer, according to top cancer researchers
YourEncore, a leading provider of expert solutions to the life sciences, consumer health and nutrition industries, today announced a partnership extension with Roche to provide expert solutions and services to support enhancing productivity and strengthening regulatory compliance.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
› Verified 8 days ago
| Entity Name | Our Lady Of Bellefonte Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104284140 PECOS PAC ID: 8527964709 Enrollment ID: O20031209000852 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Eating a balanced diet and preparing your food in the correct way may be your best defense against developing cancer, according to top cancer researchers
YourEncore, a leading provider of expert solutions to the life sciences, consumer health and nutrition industries, today announced a partnership extension with Roche to provide expert solutions and services to support enhancing productivity and strengthening regulatory compliance.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
› Verified 8 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Eating a balanced diet and preparing your food in the correct way may be your best defense against developing cancer, according to top cancer researchers
YourEncore, a leading provider of expert solutions to the life sciences, consumer health and nutrition industries, today announced a partnership extension with Roche to provide expert solutions and services to support enhancing productivity and strengthening regulatory compliance.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Debra K Martin, NP Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Ms Debra K Martin, NP 1180 Saint Christopher Dr, Ashland, KY 41101-7055 Ph: (606) 833-6243 |
News Archive
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
Eating a balanced diet and preparing your food in the correct way may be your best defense against developing cancer, according to top cancer researchers
YourEncore, a leading provider of expert solutions to the life sciences, consumer health and nutrition industries, today announced a partnership extension with Roche to provide expert solutions and services to support enhancing productivity and strengthening regulatory compliance.
Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration
› Verified 8 days ago
Lisa Ellen Spencer, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Tomie Thompson, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1000 Ashland Dr, Ste G1, Ashland, KY 41101 Phone: 606-833-4043 | |
Susan Aliff, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 520, Ashland, KY 41101 Phone: 606-393-0190 | |
Tracy Ricewick, AGNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 | |
Rita Nicole Fletcher, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 399 Diederich Blvd, Ashland, KY 41101 Phone: 606-324-8060 Fax: 606-325-6889 | |
Darren Barker, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 440, Ashland, KY 41101 Phone: 606-329-2888 | |
Martina Renate Myers, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6825 |